IN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million
2021年5月27日 - 5:28AM
Alliance News
IM cash shell
which acquired BiVictriX Therapeutics Ltd for GBP5.5 million -
Proposes name change to BiVictriX Therape ...
Subscribe now to see this Premium News
article from
Alliance News Professional covers every UK
stock in your portfolio. It goes beyond regulatory news and free
web services to give your investment decisions an edge over the
crowd.
- In The
Know - Management and analyst comments that go beyond company
announcements.
- Flash headlines on all 2,400 London-listed companies before the
news hits the open web.
- Broker Ratings - The
earliest tip-offs, many before the market opens.
- Economic data and central bank flashes from UK, US and
eurozone.
- Taking
AIM - Up to the minute market commentary on AIM stocks.
- Over 500 news items per trading day for just £39.60 per month,
and cancel at any time.
Call us on +44 (0) 203 8794 460 to get
started.
Motif Bio (LSE:MTFB)
過去 株価チャート
から 11 2024 まで 12 2024
Motif Bio (LSE:MTFB)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Motif Bio Plc (ロンドン証券取引所): 0 recent articles
その他のニュース記事